Ultragenyx Pharmaceutical (RARE) Amortizatization of Intangibles (2013 - 2026)
Ultragenyx Pharmaceutical (RARE) reported Amortizatization of Intangibles of $1.0 million for Q1 2026, down 50.0% year-over-year from $2.0 million in Q1 2025, and up 93.8% on a QoQ basis from $516000.0 in Q4 2025.
Ultragenyx Pharmaceutical (RARE) has 14 years of Amortizatization of Intangibles data on file, last reported at $1.0 million in Q1 2026.
- Quarterly Amortizatization of Intangibles fell 50.0% year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.0 million (down 73.32% YoY) and the FY2025 annual result came in at $4.0 million, down 69.23% from the prior year.
- Amortizatization of Intangibles advanced to $1.0 million in Q1 2026 per RARE's latest filing, from $516000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $4.1 million in Q4 2023 and bottomed at -$1.9 million in Q1 2022.
- The 5-year median for Amortizatization of Intangibles is $2.0 million (2025), against an average of $1.7 million.
- The widest annual swing landed in 2022, when Amortizatization of Intangibles sank 101.49%; it then jumped 376.68% in 2023.
- Tracing RARE's Amortizatization of Intangibles over 5 years: stood at $1.6 million in 2022, then surged by 148.85% to $4.1 million in 2023, then dropped by 22.5% to $3.2 million in 2024, then slumped by 83.78% to $516000.0 in 2025, then soared by 93.8% to $1.0 million in 2026.
- Per Business Quant, the three latest RARE Amortizatization of Intangibles figures stand at $1.0 million (Q1 2026), $516000.0 (Q4 2025), and $704000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Ultragenyx Pharmaceutical | 2.29 Bn | 1.89 Bn | 106.00 Mn | 1.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.00 Mn |
| Mar 31, 2026 | 1.00 Mn |
| Dec 31, 2025 | 516,000.00 |
| Dec 31, 2025 | 516,000.00 |
| Sep 30, 2025 | 704,000.00 |
| Sep 30, 2025 | 704,000.00 |
| Jun 30, 2025 | 780,000.00 |
| Jun 30, 2025 | 780,000.00 |
| Mar 31, 2025 | 2.00 Mn |
| Mar 31, 2025 | 2.00 Mn |
| Dec 31, 2024 | 3.18 Mn |
| Dec 31, 2024 | 3.18 Mn |
| Sep 30, 2024 | 3.12 Mn |
| Sep 30, 2024 | 3.12 Mn |
| Jun 30, 2024 | 2.95 Mn |
| Jun 30, 2024 | 2.95 Mn |
| Mar 31, 2024 | 3.76 Mn |
| Mar 31, 2024 | 3.76 Mn |
| Dec 31, 2023 | 4.11 Mn |
| Dec 31, 2023 | 4.11 Mn |
| Sep 30, 2023 | 2.68 Mn |
| Sep 30, 2023 | 2.68 Mn |
| Jun 30, 2023 | 3.22 Mn |
| Jun 30, 2023 | 3.22 Mn |
| Mar 31, 2023 | 2.99 Mn |
| Mar 31, 2023 | 2.99 Mn |
| Dec 31, 2022 | 1.65 Mn |
| Dec 31, 2022 | 1.65 Mn |
| Sep 30, 2022 | -969,000.00 |
| Sep 30, 2022 | -969,000.00 |
| Jun 30, 2022 | -1.49 Mn |
| Jun 30, 2022 | -1.49 Mn |
| Mar 31, 2022 | -1.89 Mn |
| Mar 31, 2022 | -1.89 Mn |
| Dec 31, 2021 | -2.11 Mn |
| Dec 31, 2021 | -2.11 Mn |
| Sep 30, 2021 | -1.99 Mn |
| Sep 30, 2021 | -1.99 Mn |
| Jun 30, 2021 | -1.57 Mn |
| Jun 30, 2021 | -1.57 Mn |
| Mar 31, 2021 | -940,000.00 |
| Mar 31, 2021 | -940,000.00 |
| Dec 31, 2020 | -631,000.00 |
| Dec 31, 2020 | -631,000.00 |
| Sep 30, 2020 | -366,000.00 |
| Sep 30, 2020 | -366,000.00 |
| Jun 30, 2020 | -150,000.00 |
| Jun 30, 2020 | -150,000.00 |
| Mar 31, 2020 | 299,000.00 |
| Mar 31, 2020 | 299,000.00 |
| Dec 31, 2019 | 1.28 Mn |
| Dec 31, 2019 | 1.28 Mn |
| Sep 30, 2019 | 1.97 Mn |
| Sep 30, 2019 | 1.97 Mn |
| Jun 30, 2019 | 2.12 Mn |
| Jun 30, 2019 | 2.12 Mn |
| Mar 31, 2019 | 839,000.00 |
| Mar 31, 2019 | 839,000.00 |
| Dec 31, 2018 | 809,000.00 |
| Dec 31, 2018 | 809,000.00 |
| Sep 30, 2018 | 919,000.00 |
| Sep 30, 2018 | 919,000.00 |
| Jun 30, 2018 | 674,000.00 |
| Jun 30, 2018 | 674,000.00 |
| Mar 31, 2018 | 239,000.00 |
| Mar 31, 2018 | 239,000.00 |
| Dec 31, 2017 | -255,000.00 |
| Dec 31, 2017 | -255,000.00 |
| Sep 30, 2017 | -400,000.00 |
| Sep 30, 2017 | -400,000.00 |
| Jun 30, 2017 | -1.60 Mn |
| Jun 30, 2017 | -1.60 Mn |
| Mar 31, 2017 | 549,000.00 |
| Mar 31, 2017 | 549,000.00 |
| Dec 31, 2016 | -612,000.00 |
| Dec 31, 2016 | -612,000.00 |
| Sep 30, 2016 | -1.02 Mn |
| Sep 30, 2016 | -1.02 Mn |
| Jun 30, 2016 | -1.39 Mn |
| Jun 30, 2016 | -1.39 Mn |
| Mar 31, 2016 | -1.83 Mn |
| Mar 31, 2016 | -1.83 Mn |
| Dec 31, 2015 | -1.94 Mn |
| Dec 31, 2015 | -1.94 Mn |
| Sep 30, 2015 | -1.47 Mn |
| Sep 30, 2015 | -1.47 Mn |
| Jun 30, 2015 | -1.27 Mn |
| Jun 30, 2015 | -1.27 Mn |
| Mar 31, 2015 | -965,000.00 |
| Mar 31, 2015 | -965,000.00 |
| Dec 31, 2014 | -1.16 Mn |
| Dec 31, 2014 | -1.16 Mn |
| Sep 30, 2014 | -1.05 Mn |
| Sep 30, 2014 | -1.05 Mn |
| Jun 30, 2014 | -917,000.00 |
| Jun 30, 2014 | -917,000.00 |
| Mar 31, 2014 | -479,000.00 |
| Mar 31, 2014 | -479,000.00 |
| Dec 31, 2013 | -441,000.00 |
| Dec 31, 2013 | -441,000.00 |
| Sep 30, 2013 | -607,000.00 |
| Sep 30, 2013 | -607,000.00 |
| Jun 30, 2013 | -371,000.00 |
| Jun 30, 2013 | -371,000.00 |
| Mar 31, 2013 | 6,000.00 |
| Mar 31, 2013 | 6,000.00 |